Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M105,544Revenue (TTM) $M36,852Net Margin (%)2.5Altman Z-Score1.4
Enterprise Value $M126,403EPS (TTM) $0.4Operating Margin %7.5Piotroski F-Score4
P/E(ttm)122Beneish M-Score-2.6Pre-tax Margin (%)4.7Higher ROA y-yN
Price/Book27.510-y EBITDA Growth Rate %1.7Quick Ratio0.8Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %7.5Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow143y-y EBITDA Growth Rate %-73.8ROA % (ttm)1.1Higher Current Ratio y-yN
Dividend Yield %5.4PEG15.5ROE % (ttm)11.1Less Shares Outstanding y-yN
Payout Ratio %682Shares Outstanding M2,435ROIC % (ttm)7.7Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKHOTCHKIS & WILEY 2016-03-31 Reduce-0.52%$38.54 - $42.05
($39.84)
$ 43.349%Reduce -26.34%8,915,323
GSKKahn Brothers 2016-03-31 Add0.36%$38.54 - $42.05
($39.84)
$ 43.349%Add 55.97%131,950
GSKCharles Brandes 2016-03-31 Add0.1%$38.54 - $42.05
($39.84)
$ 43.349%Add 3.98%4,474,409
GSKJohn Rogers 2016-03-31 Add0.05%$38.54 - $42.05
($39.84)
$ 43.349%Add 7.17%1,582,913
GSKNWQ Managers 2016-03-31 Add0.02%$38.54 - $42.05
($39.84)
$ 43.349%Add 6.02%498,115
GSKTweedy Browne 2016-03-31 Reduce-0.02%$38.54 - $42.05
($39.84)
$ 43.349%Reduce -12.81%116,070
GSKKen Fisher 2016-03-31 Add0.01%$38.54 - $42.05
($39.84)
$ 43.349%Add 1.09%11,657,855
GSKJoel Greenblatt 2016-03-31 Reduce$38.54 - $42.05
($39.84)
$ 43.349%Reduce -1.24%51,331
GSKBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Add$38.54 - $42.05
($39.84)
$ 43.349%Add 1.12%251,800
GSKDodge & Cox 2016-03-31 Reduce$38.54 - $42.05
($39.84)
$ 43.349%Reduce -27.95%81,262
GSKCharles Brandes 2015-12-31 Reduce-0.21%$39.1 - $43.53
($40.81)
$ 43.346%Reduce -7.92%4,303,030
GSKKahn Brothers 2015-12-31 Add0.2%$39.1 - $43.53
($40.81)
$ 43.346%Add 47.13%84,600
GSKHOTCHKIS & WILEY 2015-12-31 Reduce-0.05%$39.1 - $43.53
($40.81)
$ 43.346%Reduce -2.40%12,102,919
GSKJohn Rogers 2015-12-31 Add0.01%$39.1 - $43.53
($40.81)
$ 43.346%Add 1.29%1,476,976
GSKKen Fisher 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 43.346%Add 0.03%11,531,673
GSKTweedy Browne 2015-12-31 Reduce$39.1 - $43.53
($40.81)
$ 43.346%Reduce -0.25%133,124
GSKNWQ Managers 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 43.346%Add 1.68%469,830
GSKDodge & Cox 2015-12-31 Reduce$39.1 - $43.53
($40.81)
$ 43.346%Reduce -44.42%112,782
GSKJoel Greenblatt 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 43.346%Add 1.01%51,973
GSKDodge & Cox 2015-09-30 Reduce-0.46%$37.56 - $45.14
($41.64)
$ 43.344%Reduce -98.37%202,915
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2293view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14100.85view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29702.65view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12253.83view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14203.29view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12253.83view

Press Releases about GSK :

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    Jeff Auxier Sells Precision Castparts, AT&T, Microsoft Jun 23 2016 
    Steven Cohen Adds to Stake in Pernix Therapeutics Jun 07 2016 
    PhaseRX: The Latest Pick From a Legendary VC Firm May 24 2016 
    Kahn Brothers Adds to BP, GlaxoSmithKline Stakes May 10 2016 
    A Closer Look Into Veritas Pharma Apr 21 2016 
    Dividend and Value Opportunities in the Large-Cap Pharmaceutical Space Apr 05 2016 
    Why the UK Is Headed For a Slowdown Mar 23 2016 
    Insiders Roundup: Theravance Biopharma, Western Gas, Upland Software Mar 18 2016 
    Brandes Makes a Variety of Reductions in 4th Quarter Feb 11 2016 
    10 Fund Managers Are Totally Wrong on GlaxoSmithKline Jan 26 2016 

    More From Other Websites
    Limited protection of GSK's malaria vaccine dwindles in 7 years Jun 29 2016
    New partnership looks to improve lives of children living with HIV Jun 29 2016
    3 Stocks That Could Surge In Q3! Randgold Resources Limited, GlaxoSmithKline plc and British... Jun 29 2016
    Shire and Glaxo Offer Prescription to London's Woes Jun 28 2016
    Mylan Launches Generic Version of Glaxo's Avodart in U.S. Jun 27 2016
    How Does Brexit Impact Healthcare Stocks? Jun 27 2016
    These 3 UK business sectors may be hit hard by Brexit Jun 27 2016
    6 ways Brexit could impact Washington business Jun 27 2016
    Should you buy Neil Woodford’s top 3 holdings Imperial Brands plc, AstraZeneca plc &... Jun 27 2016
    UW researchers compete for $1M prize from GlaxoSmithKline with device for bladder control, sexual... Jun 24 2016
    Mylan Unveils Generic Avodart Capsules Jun 24 2016
    Brexit spells upheaval for EU and UK drug regulation Jun 24 2016
    GlaxoSmithKline Has No Cure for Sideways Action Jun 23 2016
    GAVI alliance offers matched funds for GSK malaria vaccine pilot Jun 23 2016
    Why GlaxoSmithKline plc looks set to be beaten by Inmarsat Plc Jun 23 2016
    GlaxoSmithKline plc vs Smith & Nephew plc: which is the FTSE 100’s best medical marvel? Jun 22 2016
    3 of my best ever dividend stocks: GlaxoSmithKline plc, Aviva plc and Royal Mail plc Jun 21 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)